Pediatricians' intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing.

The Robert Wood Johnson Clinical Scholars Program, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Journal of Adolescent Health (Impact Factor: 2.75). 11/2008; 43(4):408-11. DOI: 10.1016/j.jadohealth.2008.06.012
Source: PubMed

ABSTRACT We surveyed 105 pediatric clinicians following Human papillomavirus (HPV) vaccine licensure to identify factors associated with intention to recommend the vaccine to 11- to 12-year-old girls. Pediatricians who were early adopters of medical technologies had fewer concerns about HPV vaccine safety/efficacy, and who anticipated parental vaccine safety/efficacy concerns reported higher intention to recommend the vaccine.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Two human papillomavirus vaccines were licenced in 2006/2007 for cervical cancer prevention. National vaccination programmes for schoolgirls were subsequently introduced in some European countries, North America and Australia. To understand factors influencing vaccine uptake and to inform the development of appropriate UK educational materials, we aimed to synthesise evidence of girls' and parents' information needs, views and preferences regarding HPV vaccination. Systematic review and mixed method synthesis of qualitative and survey data. 12 electronic databases; bibliographies of included studies 1980 to August 2011. Two reviewers independently screened papers and appraised study quality. Studies were synthesised collaboratively using framework methods for qualitative data, and survey results integrated where they supported, contrasted or added to the themes identified. Twenty-eight qualitative studies and 44 surveys were included. Where vaccination was offered, uptake was high. Intention to decline was related to a preference for vaccinating later to avoid appearing to condone early sexual activity, concerns about vaccine safety and low perception of risk of HPV infection. Knowledge was poor and there were many misconceptions; participants tried to assess the potential benefits and harms of vaccination but struggled to interpret limited information about HPV in the context of existing knowledge about sexually transmitted infections and cancer. Conclusion Many girls and their parents have limited understanding to an extent that impinges on their ability to make informed choices about HPV vaccination and could impact on future uptake of cervical screening. This is a considerable challenge to those who design and provide information, but getting the messages right for this programme could help in developing patient information about other HPV related cancers.
    Vaccine 09/2013; · 3.49 Impact Factor
  • Source
    Journal of Adolescent Health 02/2011; 48(2):S4–S5. · 2.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: AimsThe purpose of this study was to assess the standpoint of family physicians in the Southern French region Provence-Alpes-Cote d’Azur concerning human Papillomavirus vaccination and to evaluate the factors associated with a favorable standpoint.
    Médecine et Maladies Infectieuses 10/2009; 39(10):789-797. · 0.91 Impact Factor